EGF Theramed Health Corp. (CSE:TMED.X)
Canada · Delayed Price · Currency is CAD 0.0550
0.00 (0.00%)
Aug 11, 2026, 11:18 AM EST
EGF Theramed Health Balance Sheet
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.7 |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Cash & Short-Term Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.7 |
Cash Growth | -54.64% | 39.96% | -14.58% | -23.06% | -97.83% | 17.12% |
Other Receivables | 0 | - | 0.2 | 0.17 | 0.15 | 0.14 |
Receivables | 0 | - | 0.2 | 0.17 | 0.15 | 0.14 |
Prepaid Expenses | 0 | 0.01 | 0 | 0.01 | 0.01 | 0.01 |
Total Current Assets | 0.02 | 0.02 | 0.21 | 0.19 | 0.18 | 0.85 |
Other Intangible Assets | - | - | - | - | - | 0.35 |
Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 0 |
Total Assets | 0.02 | 0.02 | 0.21 | 0.19 | 0.18 | 1.2 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 1.34 | 1.32 | 1.33 | 1.26 | 0.99 | 0.92 |
Accrued Expenses | 0.16 | 0.02 | 0.01 | - | - | 0.32 |
Short-Term Debt | 1.09 | 0.99 | 1 | 0.92 | 0.84 | 0.77 |
Current Portion of Long-Term Debt | 0 | 0 | 0 | 0 | - | - |
Current Portion of Leases | 0.57 | 0.52 | 0.47 | 0.42 | 0.38 | - |
Current Income Taxes Payable | 2.94 | 2.94 | - | - | - | - |
Other Current Liabilities | - | 0.14 | 0.1 | 0.07 | 0.3 | 0.05 |
Total Current Liabilities | 6.11 | 5.93 | 2.92 | 2.67 | 2.51 | 2.06 |
Long-Term Debt | - | - | - | - | 0 | 0 |
Long-Term Leases | - | - | - | - | - | 0.35 |
Total Liabilities | 6.11 | 5.93 | 2.92 | 2.67 | 2.51 | 2.41 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 50.6 | 50.6 | 50.58 | 50.48 | 50.21 | 50.02 |
Additional Paid-In Capital | 4.13 | 4.13 | 4.13 | 4.16 | 3.93 | 3.88 |
Retained Earnings | -59.44 | -59.28 | -56.08 | -55.81 | -55.18 | -53.83 |
Comprehensive Income & Other | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Total Common Equity | -4.68 | -4.52 | -1.34 | -1.14 | -1.02 | 0.09 |
Minority Interest | -1.41 | -1.39 | -1.36 | -1.34 | -1.32 | -1.3 |
Shareholders' Equity | -6.1 | -5.91 | -2.7 | -2.48 | -2.34 | -1.21 |
Total Liabilities & Equity | 0.02 | 0.02 | 0.21 | 0.19 | 0.18 | 1.2 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 1.66 | 1.51 | 1.47 | 1.34 | 1.22 | 1.12 |
Net Cash (Debt) | -1.65 | -1.5 | -1.46 | -1.33 | -1.2 | -0.42 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.14 | -0.13 | -0.13 | -0.13 | -0.56 | -0.39 |
Filing Date Shares Outstanding | 11.62 | 11.62 | 11.62 | 11.39 | 2.16 | 2.16 |
Total Common Shares Outstanding | 11.62 | 11.62 | 11.39 | 10.49 | 2.16 | 2.05 |
Working Capital | -6.1 | -5.91 | -2.71 | -2.48 | -2.34 | -1.21 |
Book Value Per Share | -0.40 | -0.39 | -0.12 | -0.11 | -0.47 | 0.04 |
Tangible Book Value | -4.68 | -4.52 | -1.34 | -1.14 | -1.02 | -0.25 |
Tangible Book Value Per Share | -0.40 | -0.39 | -0.12 | -0.11 | -0.47 | -0.12 |